Table 3 Comparison of Morgaf and clinician responses.
Case groups | Morgaf’s response success (%) | Clinician response success (%) | p value |
---|---|---|---|
pSLE | 100 | 100 | 0.297 |
non-pSLE | 93 | 70 | 0.034 |
HCs | 100 | 100 | 0.422 |
Case groups | Morgaf’s response success (%) | Clinician response success (%) | p value |
---|---|---|---|
pSLE | 100 | 100 | 0.297 |
non-pSLE | 93 | 70 | 0.034 |
HCs | 100 | 100 | 0.422 |